Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
RAD:ASX
Radiopharm Theranostics Ltd
A$0.020
0.00%
(0.00) 1D
Apr 29, 3:47:33 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RAD...
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
74.43M
Avg. vol.
3.44M
Volume
935.66K
52-wk high
A$0.04
52-wk low
A$0.02
EPS
-A$0.02
Shares outstanding
3.54B
No. of employees
14
News stories
From sources across the web
About Radiopharm Theranostics Ltd
CEO-
Employees14
Founded2021
Headquarters-
SectorBiotechnology
Last report
Jan 29, 2025
Fiscal Period
Q2 2025
Normalized EPS / Estimate
-0.01/ (-0.01 est.)USD
+9.57%beat
Revenue / Estimate
859.04K/ (0.00 est.)USD
+∞%beat
Fiscal Q2 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
5.04M
5.04M
3.10M
3.10M
Cost of goods sold
7.95M
7.95M
11.30M
11.30M
Cost of revenue
7.95M
7.95M
11.30M
11.30M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.15M
4.15M
4.18M
4.18M
Operating expense
4.75M
4.75M
4.95M
4.95M
Total operating expenses
12.70M
12.70M
16.25M
16.25M
Operating income
-7.66M
-7.66M
-13.14M
-13.14M
Other non operating income
-143.00
-143.00
-
-
EBT including unusual items
-9.35M
-9.35M
-14.05M
-14.05M
EBT excluding unusual items
-7.54M
-7.54M
-13.37M
-13.37M
Income tax expense
1.16K
1.16K
67.15K
67.15K
Effective tax rate
-0.01%
-0.01%
-0.48%
-0.48%
Other operating expenses
-
-
-
-
Net income
-9.81M
-9.81M
-13.48M
-13.48M
Net profit margin
-194.71%
-194.71%
-434.67%
-434.67%
Earnings per share
-
-
-
-
Interest and investment income
444.10K
444.10K
-
-
Interest expense
-32.65K
-32.65K
-32.55K
-32.55K
Net interest expenses
411.45K
411.45K
-32.55K
-32.55K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.12M
-7.12M
-12.47M
-12.47M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more